During the past decade, NHRMC Radiation Oncology - Supply conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 8 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 6 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "NHRMC Radiation Oncology - Supply" #1 sponsor was "NRG Oncology" with 9 trials, followed by "Radiation Therapy Oncology Group" with 5 trials sponsored, "Alliance for Clinical Trials in Oncology" with 3 trials sponsored, "Coastal Carolina Radiation Oncology" with 2 trials sponsored and "National Cancer Institute (NCI)" with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "NHRMC Radiation Oncology - Supply" #1 collaborator was "National Cancer Institute (NCI)" with 21 trials as a collaborator, "NRG Oncology" with 6 trials as a collaborator, "New Hanover Regional Medical Center" with 2 trials as a collaborator, "Canadian Cancer Trials Group" with 1 trials as a collaborator and "Radiation Therapy Oncology Group" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "NHRMC Radiation Oncology - Supply" are "Prostate Adenocarcinoma" (4 trials), "Prostate Cancer" (3 trials), "Lung Non-Small Cell Carcinoma" (2 trials), "Metastatic Malignant Neoplasm in the Bone" (2 trials) and "Stage I Lung Cancer AJCC v8" (2 trials). Many other conditions were trialed in "NHRMC Radiation Oncology - Supply" in a lesser frequency.

Most popular intervention types in "NHRMC Radiation Oncology - Supply" are "Radiation" (19 trials), "Drug" (14 trials), "Other" (7 trials), "Procedure" (4 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Questionnaire Administration" (5 trials), "Cisplatin" (3 trials), "Quality-of-Life Assessment" (3 trials), "Apalutamide" (2 trials) and "Bicalutamide" (2 trials). Other intervention names were less common.

The vast majority of trials in "NHRMC Radiation Oncology - Supply" are 9 trials for "All" genders, 9 trials for "Male" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "NHRMC Radiation Oncology - Supply". undefined are not yet recruiting, 3 are recruiting, 14 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in NHRMC Radiation Oncology - Supply, 2 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in NHRMC Radiation Oncology - Supply, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".